LIST OF BINDING INTERFACES for query 'EPHRIN TYPE-A RECEPTOR 2' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details
5i9x	DB8	Bosutinib (DB06616)	Bosutinib is an antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments.	EPHRIN TYPE-A RECEPTOR 2 (Homo sapiens)	PK_Tyr_Ser-Thr	5I9X_A_DB8A1001	Details
5i9y	1N1	Dasatinib (DB01254)	Dasatinib is a tyrosine kinase inhibitor used for the treatment of lymphoblastic or chronic myeloid leukemia with resistance or intolerance to prior therapy.	EPHRIN TYPE-A RECEPTOR 2 (Homo sapiens)	PK_Tyr_Ser-Thr	5I9Y_A_1N1A1001	Details
6nk0	ACA	Aminocaproic acid (DB00513)	Aminocaproic acid is an antifibrinolytic agent used to induce clotting postoperatively.	EPHRIN TYPE-A RECEPTOR 2 (Homo sapiens; synthetic construct)	NA	6NK0_A_ACAA302	Details
PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details

[["5i9x","DB8","Bosutinib (DB06616)","Homo sapiens","EPHRIN TYPE-A RECEPTOR 2","PK_Tyr_Ser-Thr"],["5i9y","1N1","Dasatinib (DB01254)","Homo sapiens","EPHRIN TYPE-A RECEPTOR 2","PK_Tyr_Ser-Thr"],["6nk0","ACA","Aminocaproic acid (DB00513)","Homo sapiens;synthetic construct","EPHRIN TYPE-A RECEPTOR 2","NA"]]